Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Journal of Wildlife Diseases
|
October 6, 2018
SURVEY OF ARCTIC ALASKAN WILDLIFE FOR INFLUENZA A ANTIBODIES: LIMITED EVIDENCE FOR EXPOSURE OF MAMMALS
Caroline Van Hemert, Timothy J Spivey, Brian D Uher-Koch, et al.
Nature
|
November 3, 2020
Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City
Daniel Stadlbauer, Jessica Tan, Kaijun Jiang, et al.
NPJ Vaccines
|
July 4, 2026
Muscle macrophage regenerative response after squalene-adjuvanted influenza vaccination is associated with type II-skewed response and is reduced with age
Moataz Noureddine, Lauren A Chang, Farah El Ayache, et al.
NPJ Vaccines
|
November 21, 2025
Immunogenicity and efficacy of homologous and heterologous NDV and MVA SARS-CoV-2 vaccines in mice and hamsters
Patricia Pérez, Kaijun Jiang, Irene González-Domínguez, et al.
The Journal of Experimental Medicine
|
December 5, 2025
Autoantibodies neutralizing type I IFNs in a fatal case of H5N1 avian influenza
Qian Zhang, Taylor S Conrad, Marcela Moncada-Velez, et al.
The Journal of Infectious Diseases
|
April 6, 2021
Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers
Ricardo da Silva Antunes, Suresh Pallikkuth, Erin Williams, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 20, 2021
Differential T cell reactivity to seasonal coronaviruses and SARS-CoV-2 in community and health care workers
Ricardo da Silva Antunes, Suresh Pallikkuth, Erin Williams, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 9, 2020
A serological assay to detect SARS-CoV-2 seroconversion in humans
Fatima Amanat, Daniel Stadlbauer, Shirin Strohmeier, et al.
Nature Medicine
|
May 14, 2020
A serological assay to detect SARS-CoV-2 seroconversion in humans
Fatima Amanat, Daniel Stadlbauer, Shirin Strohmeier, et al.
Nature Medicine
|
December 8, 2020
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial
Raffael Nachbagauer, Jodi Feser, Abdollah Naficy, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Journal of Wildlife Diseases
|
October 6, 2018
SURVEY OF ARCTIC ALASKAN WILDLIFE FOR INFLUENZA A ANTIBODIES: LIMITED EVIDENCE FOR EXPOSURE OF MAMMALS
Caroline Van Hemert, Timothy J Spivey, Brian D Uher-Koch, et al.
Nature
|
November 3, 2020
Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City
Daniel Stadlbauer, Jessica Tan, Kaijun Jiang, et al.
NPJ Vaccines
|
July 4, 2026
Muscle macrophage regenerative response after squalene-adjuvanted influenza vaccination is associated with type II-skewed response and is reduced with age
Moataz Noureddine, Lauren A Chang, Farah El Ayache, et al.
NPJ Vaccines
|
November 21, 2025
Immunogenicity and efficacy of homologous and heterologous NDV and MVA SARS-CoV-2 vaccines in mice and hamsters
Patricia Pérez, Kaijun Jiang, Irene González-Domínguez, et al.
The Journal of Experimental Medicine
|
December 5, 2025
Autoantibodies neutralizing type I IFNs in a fatal case of H5N1 avian influenza
Qian Zhang, Taylor S Conrad, Marcela Moncada-Velez, et al.
The Journal of Infectious Diseases
|
April 6, 2021
Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers
Ricardo da Silva Antunes, Suresh Pallikkuth, Erin Williams, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 20, 2021
Differential T cell reactivity to seasonal coronaviruses and SARS-CoV-2 in community and health care workers
Ricardo da Silva Antunes, Suresh Pallikkuth, Erin Williams, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 9, 2020
A serological assay to detect SARS-CoV-2 seroconversion in humans
Fatima Amanat, Daniel Stadlbauer, Shirin Strohmeier, et al.
Nature Medicine
|
May 14, 2020
A serological assay to detect SARS-CoV-2 seroconversion in humans
Fatima Amanat, Daniel Stadlbauer, Shirin Strohmeier, et al.
Nature Medicine
|
December 8, 2020
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial
Raffael Nachbagauer, Jodi Feser, Abdollah Naficy, et al.
Page
of 5